Biotechnology firm Bristol Myers Squibb (NYSE: BMY) reported decrease revenue for the fourth quarter of 2024, regardless of a rise in income.
Web earnings attributable to shareholders was $72 million or $0.04 per share within the December quarter, in comparison with $1.76 billion or $0.87 per share within the comparable interval of 2023. Adjusted revenue dropped to $1.67 per share in This autumn from $1.70 per share within the prior 12 months interval.
Fourth-quarter revenues elevated 8% from final 12 months to $12.3 billion. Home revenues rose 9% and worldwide revenues moved up 5%.
